李蕾, 江泽飞. CTC detection at different stages and various subtypes of breast cancer[J]. China Oncology, 2013, 23(8): 570-575. DOI: 10.3969/j.issn.1007-3969.2013.08.002.
CTC detection at different stages and various subtypes of breast cancer
The utility of circulating tumor cells in breast cancer has been paid more attention. There are many clinical trials all over the world which concerned the whole course of breast cancer. Although the value of detecting circulating tumor cells is different at each stage of breast cancer
the advantage is significant compared with traditional methods in monitoring and evaluating diseases status. Nowadays the treatments of breast cancer are classified and individualized
it is possible to find the most timely and optimized regimens after detecting the amount and characteristics of circulating tumor cells.
The clinical value of liquid tumor biomarker detection for breast cancer
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Related Author
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
LU Ye
ZHANG Wenxiang
KONG Xiangyi
FANG Yi
WANG Jing
GAO Jidong
Related Institution
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases
Department of Laboratory Medicine, Xingtai People’s Hospital